Position history for Brevan Howard Capital Management LP's holdings in BRIDGEBIO PHARMA INC
Brevan Howard Capital Management LP holds 173,523 shares of BBIO (BRIDGEBIO PHARMA INC), worth $13.2M as of 2025-Q4. The position was increased (++231.0% shares). BBIO represents 0.1% of Brevan Howard Capital Management LP's portfolio.
Current Value
$13.2M
Current Shares
173,523
Total Value Change
+$12.8M
Total Shares Change
+160,338
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 173,523 |
+231.0% |
| $13.2M |
| 0.1% |
| $75.48 |
54 |
| 2025-Q3 | Decreased | 52,418 | -49.6% | $2.7M | 0.0% | $51.96 | 0 |
| 2025-Q2 | New | 104,110 | - | $4.5M | 0.0% | $44.86 | 37 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $35.11 | 0 |
| 2024-Q4 | Decreased | 14,760 | -39.7% | $405,014 | 0.0% | $27.32 | 0 |
| 2024-Q3 | Increased | 24,482 | +85.7% | $623,312 | 0.0% | $24.94 | 38 |
| 2024-Q2 | New | 13,185 | - | $333,976 | 0.0% | $25.33 | 33 |